ANIK compared with VRCA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIKAnika Therapeutics, Inc.

Mkt capRevenueRevenue

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

ANIKAnika Therapeutics, Inc.

VRCAVerrica Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

ANIKwithVRCA

No shared trading history for ANIK and VRCA.

Shared co-movers: not yet measured (VRCA).

ANIK, solidVRCA, hatchedr = correlationBar = r to r 0.75Source: daily closes

ANIKAnika Therapeutics, Inc.

20.98· pre 20.64· delayed

Mkt cap$280.4MRevenue$33MQ2 FY26Revenue$113MFY25

VRCAVerrica Pharmaceuticals Inc.

3.30· pre 3.40· delayed

Pre-marketOct 30 '26delayed

Mkt cap$57.5MRevenue$6MQ2 FY26Revenue$36MFY25

Compare

Pre-marketOct 30 '26delayed

ANIKAnika Therapeutics, Inc.

VRCAVerrica Pharmaceuticals Inc.

20.98pre 20.64delayed

Price

3.30pre 3.40delayed

$280.4M

Mkt cap

$57.5M

Q2 FY26$33M

Revenue

$6MQ2 FY26

FY25$113M

Revenue

$36MFY25

ANIK20.98vsVRCA3.30Pre-marketOct 30 '26delayed